dc.contributor.author | Lalatsa, Aikaterini | |
dc.contributor.author | Uchegbu, I.F. | |
dc.date.accessioned | 2014-11-13T09:29:29Z | |
dc.date.available | 2014-11-13T09:29:29Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Lalatsa , A & Uchegbu , I F 2011 , ' Oral nanomedicines for the treatment of brain diseases ' , SET for Britain 2011 , London , United Kingdom , 14/03/11 . | |
dc.identifier.citation | other | |
dc.identifier.uri | http://hdl.handle.net/2299/14751 | |
dc.language.iso | eng | |
dc.title | Oral nanomedicines for the treatment of brain diseases | en |
dc.contributor.institution | Department of Pharmacy | |
dc.contributor.institution | Health & Human Sciences Research Institute | |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Centre for Research into Topical Drug Delivery and Toxicology | |
dc.contributor.institution | Nanopharmaceutics | |
dc.contributor.institution | Pharmaceutics | |
dc.description.status | Non peer reviewed | |
rioxxterms.type | Other | |
herts.preservation.rarelyaccessed | true | |